DUET ACT 3
DUET ACT 3 Tablet is a combination medicine used for managing type 2 diabetes. It contains Glimepiride 3 mg and Metformin 500 mg (sustained release), which work together to control blood sugar levels. Glimepiride increases insulin release, while Metformin reduces glucose production and improves insulin sensitivity. The sustained-release form ensures gradual action, helping maintain stable glucose levels throughout the day with proper diet and exercise.
Related products
SITPIN D 10/100
Composition: Sitagliptin 100 mg + Dapagliflozin 10 mg. View SITPIN D 10/100 details or enquire...
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP Eq to Sitagliptin...
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M
GLIPDIP M is used for effective management of type 2 diabetes mellitus. Each tablet contains...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DAPAGLIDE 10
COMPOSITION : Dapagliflozin 10 mg
